Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model
This study has been completed.
Study NCT01332188   Information provided by Aciex Therapeutics, Inc.

First Received on April 7, 2011.   Last Updated on July 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Allergic Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Allergic
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Interventions listed in this trial
AC-170 0.05%
AC-170 0.1%
AC-170 0.24%
AC-170 0%
Sponsors listed in this trial
Aciex Therapeutics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services